Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Scarpini

Showing results (281-290 of 329) with videos related to

Pageof 33
Sort By:
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Cell|July 1, 2008
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease riskUte Dreses-Werringloer, Jean-Charles Lambert, Valérie Vingtdeux, et al.
Molecular Neurodegeneration|December 3, 2015
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
Neurobiology of Aging|February 5, 2013
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitorsFilippo Martinelli-Boneschi, Giacomo Giacalone, Giuseppe Magnani, et al.
Journal of Alzheimer'S Disease : JAD|January 26, 2011
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's diseaseFrancesco Lescai, Andrea Maria Chiamenti, Alessandra Codemo, et al.
Acta Bio-Medica : Atenei Parmensis|August 27, 2009
Frequency and clinical features of Lewy body dementia in Italian memory clinicsElisabetta Farina, Francesca Baglio, Paolo Caffarra, et al.
Plos One|February 23, 2010
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female populationMichele Mishto, Elena Bellavista, Claudia Ligorio, et al.
Geroscience|December 18, 2021
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian populationMaria Giulia Bacalini, Flavia Palombo, Paolo Garagnani, et al.
Pageof 33

Showing results (281-290 of 329) with videos related to

Sort By:
Pageof 33
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
Cell|July 1, 2008
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease riskUte Dreses-Werringloer, Jean-Charles Lambert, Valérie Vingtdeux, et al.
Molecular Neurodegeneration|December 3, 2015
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assayWendy E Heywood, Daniela Galimberti, Emily Bliss, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Mauro Zaffaroni, Lucia Moiola, et al.
Neurobiology of Aging|February 5, 2013
Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitorsFilippo Martinelli-Boneschi, Giacomo Giacalone, Giuseppe Magnani, et al.
Journal of Alzheimer'S Disease : JAD|January 26, 2011
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's diseaseFrancesco Lescai, Andrea Maria Chiamenti, Alessandra Codemo, et al.
Acta Bio-Medica : Atenei Parmensis|August 27, 2009
Frequency and clinical features of Lewy body dementia in Italian memory clinicsElisabetta Farina, Francesca Baglio, Paolo Caffarra, et al.
Plos One|February 23, 2010
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female populationMichele Mishto, Elena Bellavista, Claudia Ligorio, et al.
Geroscience|December 18, 2021
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian populationMaria Giulia Bacalini, Flavia Palombo, Paolo Garagnani, et al.
Pageof 33